SULFADOXINE, 250mg / PYRIMETHAMINE, 12.5mg, disp. tab.
STD
DORASULP2TD
Valid Article
HS Code:
300460
Last Updated on:
04/06/2025, 08:11:16
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
P01BD51
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
SULFADOXINE / PYRIMETHAMINE (SP) children
Therapeutic Action
Fixed-dose combination (FDC) of two antimalarials
Indications
Instructions for use
Resistance to sulfadoxine/pyrimethamine is becoming more and more frequent.
WHO recommends the co-administration of SP-IPTi with DTP2/Penta2, DTP3/Penta3 and measles immunization to infants, through routine EPI.
Precautions for Use
Do not use in combination with co-trimoxazole.
The dosage Sulfadoxine 500mg / Pyrimethamine 25mg is reserved to the Intermittent Preventive Treatment of malaria in Pregnant women (SP-IPTp).
Storage
Below 25°C ‐ Protect from sunlight